» Authors » Xiaoding Hu

Xiaoding Hu

Explore the profile of Xiaoding Hu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 212
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yin L, Hu X, Pei G, Tang M, Zhou Y, Zhang H, et al.
Life Sci Alliance . 2024 Feb; 7(4). PMID: 38316463
Radiation therapy (RT) is one of the most commonly used anticancer therapies. However, the landscape of cellular response to irradiation, especially to a single high-dose irradiation, remains largely unknown. In...
2.
Villodre E, Hu X, Huo L, Debeb B
J Natl Cancer Inst . 2022 Feb; 114(7):1048-1049. PMID: 35148408
No abstract available.
3.
Villodre E, Hu X, Eckhardt B, Larson R, Huo L, Yoon E, et al.
J Natl Cancer Inst . 2021 Dec; 114(4):579-591. PMID: 34893874
Background: N-Myc downstream regulated gene 1 (NDRG1) suppresses metastasis in many human malignancies, including breast cancer, yet has been associated with worse survival in patients with inflammatory breast cancer. The...
4.
Villodre E, Hu X, Larson R, Finetti P, Gomez K, Balema W, et al.
Mol Oncol . 2021 Aug; 15(10):2752-2765. PMID: 34342930
Inflammatory breast cancer (IBC) is an aggressive form of primary breast cancer characterized by rapid onset and high risk of metastasis and poor clinical outcomes. The biological basis for the...
5.
Hu X, Villodre E, Woodward W, Debeb B
J Vis Exp . 2021 Feb; (168). PMID: 33616115
Metastatic spread to the brain is a common and devastating manifestation of many types of cancer. In the United States alone, about 200,000 patients are diagnosed with brain metastases each...
6.
Hu X, Villodre E, Larson R, Rahal O, Wang X, Gong Y, et al.
Commun Biol . 2021 Jan; 4(1):72. PMID: 33452400
Inflammatory breast cancer (IBC) is a clinically distinct and highly aggressive form of breast cancer with rapid onset and a strong propensity to metastasize. The molecular mechanisms underlying the aggressiveness...
7.
Liu W, Hu X, Mu X, Tian Q, Gao T, Ge R, et al.
Dermatol Ther . 2021 Jan; 34(2):e14751. PMID: 33406278
Aberrant expression of long non-coding RNA (lncRNA) zinc finger protein, FOG family member 2 antisense RNA 1 (ZFPM2-AS1) has been identified in many tumors, but its role in cutaneous malignant...
8.
Fukumura K, Malgulwar P, Fischer G, Hu X, Mao X, Song X, et al.
Acta Neuropathol . 2021 Jan; 141(2):303-321. PMID: 33394124
The deadly complication of brain metastasis (BM) is largely confined to a relatively narrow cross-section of systemic malignancies, suggesting a fundamental role for biological mechanisms shared across commonly brain metastatic...
9.
Villodre E, Gong Y, Hu X, Huo L, Yoon E, Ueno N, et al.
Cancers (Basel) . 2020 Dec; 12(12). PMID: 33321961
NDRG1 is widely described as a metastasis suppressor in breast cancer. However, we found that NDRG1 is critical in promoting tumorigenesis and brain metastasis in mouse models of inflammatory breast...
10.
Zhao Y, Hu X, Wei L, Song D, Wang J, You L, et al.
Oncogene . 2018 Mar; 37(22):2921-2935. PMID: 29515234
ADP-ribosylation, including poly-ADP-ribosylation (PARylation) and mono-ADP-ribosylation (MARylation), is a multifunctional post-translational modification catalyzed by intracellular ADP-ribosyltransferases (ARTDs or PARPs). Although PARylation has been investigated most thoroughly, the function of MARylation...